Abstract
Background: Advanced molecular mechanism research incorporated with multidisciplinary collaborations on congenital heart disease has prompted new insight into its cause, development, and outcomes. Summary: This literature review aims to comprehensively examine the genetic molecular mechanisms of congenital heart disease and explain current prospects and challenges in this field. Through a systematic exploration of etiology, embryology, clinical outcomes, algorithms, and ethics, we seek to shed light on the path toward improved diagnostics, treatments, and outcomes for patients. Key Message: Collaboration among genetic researchers, clinicians, data scientists, ethicists, and policymakers is crucial to address challenges and translate research findings into tangible benefits for CHD patients.
Journal Section:
Review Article
References
1.
Bellsham-Revell
H
, Burch
M
. Congenital heart disease in infancy and childhood
. Medicine
. 2022
;50
(9
):579
–86
. 2.
Wu
W
, He
J
, Shao
X
. Incidence and mortality trend of congenital heart disease at the global, regional, and national level, 1990-2017
. Medicine
. 2020
;99
(23
):e20593
. 3.
Paç
FA
, Aydemir
MM
, Eriş
D
, Sayin
S
, Aladağ
P
, Paç
M
. Prevalence, clinical features and complications of grown-up congenital heart disease: single-center clinical experience
. Prog Cardiol
. 2022
;2
:1
–10
.4.
Morton
SU
, Shimamura
A
, Newburger
PE
, Opotowsky
AR
, Quiat
D
, Pereira
AC
, et al. Association of damaging variants in genes with increased cancer risk among patients with congenital heart disease
. JAMA Cardiol
. 2021
;6
(4
):457
–62
. 5.
Gelb
BD
. Prospects for precision genetic medicine in congenital heart disease
. Curr Opin Genet Dev
. 2022
;77
:101983
. 6.
Whittemore
R
, Hobbins
JC
, Engle
MA
. Pregnancy and its outcome in women with and without surgical treatment of congenital heart disease
. Am J Cardiol
. 1982
;50
(3
):641
–51
. 7.
Diab
NS
, Barish
S
, Dong
W
, Zhao
S
, Allington
G
, Yu
X
, et al. Molecular genetics and complex inheritance of congenital heart disease
. Genes
. 2021
;12
(7
):1020
. 8.
Goldmuntz
E
, Geiger
E
, Benson
DW
. NKX2.5 mutations in patients with tetralogy of Fallot
. Circulation
. 2001
;104
(21
):2565
–8
. 9.
Sanchez-Castro
M
, Eldjouzi
H
, Charpentier
E
, Busson
PF
, Hauet
Q
, Lindenbaum
P
, et al. Search for rare copy-number variants in congenital heart defects identifies novel candidate genes and a potential role for FOXC1 in patients with coarctation of the aorta
. Circ Cardiovasc Genet
. 2016
;9
(1
):86
–94
. 10.
Guida
V
, Sparascio
FP
, Bernardini
L
, Pancheri
F
, Melis
D
, Cocciadiferro
D
, et al. Copy number variation analysis implicates novel pathways in patients with oculo-auriculo-vertebral-spectrum and congenital heart defects
. Clin Genet
. 2021
;100
(3
):268
–79
. 11.
Reuter
MS
, Chaturvedi
RR
, Liston
E
, Manshaei
R
, Aul
RB
, Bowdin
S
, et al. The Cardiac Genome Clinic: implementing genome sequencing in pediatric heart disease
. Genet Med
. 2020
;22
(6
):1015
–24
. 12.
Granados-Riveron
JT
, Pope
M
, Bu'lock
FA
, Thornborough
C
, Eason
J
, Setchfield
K
, et al. Combined mutation screening of NKX2-5, GATA4, and TBX5 in congenital heart disease: multiple heterozygosity and novel mutations
. Congenit Heart Dis
. 2012
;7
(2
):151
–9
. 13.
Bruneau
BG
. The developmental genetics of congenital heart disease
. Nature
. 2008
;451
(7181
):943
–8
. 14.
Verhoeven
MC
, Haase
C
, Christoffels
VM
, Weidinger
G
, Bakkers
J
. Wnt signaling regulates atrioventricular canal formation upstream of BMP and Tbx2
. Birth Defects Res A Clin Mol Teratol
. 2011
;91
(6
):435
–40
. 15.
Chi
C
, Knight
WE
, Riching
AS
, Zhang
Z
, Tatavosian
R
, Zhuang
Y
, et al. Interferon hyperactivity impairs cardiogenesis in Down syndrome via downregulation of canonical Wnt signaling
. iScience
. 2023
;26
(7
):107012
. 16.
Aguayo-Gomez
A
, Arteaga-Vazquez
J
, Svyryd
Y
, Calderón-Colmenero
J
, Zamora-González
C
, Vargas-Alarcón
G
, et al. Identification of copy number variations in isolated tetralogy of Fallot
. Pediatr Cardiol
. 2015
;36
(8
):1642
–6
. 17.
Postma
AV
, Bezzina
CR
, Christoffels
VM
. Genetics of congenital heart disease: the contribution of the noncoding regulatory genome
. J Hum Genet
. 2016
;61
(1
):13
–9
. 18.
Zhang
TN
, Wu
QJ
, Liu
YS
, Lv
JL
, Sun
H
, Chang
Q
, et al. Environmental risk factors and congenital heart disease: an umbrella review of 165 systematic reviews and meta-analyses with more than 120 million participants
. Front Cardiovasc Med
. 2021
;8
:640729
. 19.
Li
AH
, Hanchard
NA
, Furthner
D
, Fernbach
S
, Azamian
M
, Nicosia
A
, et al. Whole exome sequencing in 342 congenital cardiac left sided lesion cases reveals extensive genetic heterogeneity and complex inheritance patterns
. Genome Med
. 2017
;9
(1
):95
. 20.
Barlow
GM
, Chen
XN
, Shi
ZY
, Lyons
GE
, Kurnit
DM
, Celle
L
, et al. Down syndrome congenital heart disease: a narrowed region and a candidate gene
. Genet Med
. 2001
;3
(2
):91
–101
. 21.
Pelleri
MC
, Gennari
E
, Locatelli
C
, Piovesan
A
, Caracausi
M
, Antonaros
F
, et al. Genotype-phenotype correlation for congenital heart disease in Down syndrome through analysis of partial trisomy 21 cases
. Genomics
. 2017
;109
(5–6
):391
–400
. 22.
Urban
Z
, Riazi
S
, Seidl
TL
, Katahira
J
, Smoot
LB
, Chitayat
D
, et al. Connection between elastin haploinsufficiency and increased cell proliferation in patients with supravalvular aortic stenosis and Williams-Beuren syndrome
. Am J Hum Genet
. 2002
;71
(1
):30
–44
. 23.
Yuan
SM
. Congenital heart defects in Williams syndrome
. Turk J Pediatr
. 2017
;59
(3
):225
–32
. 24.
Zhou
J
, Wu
Y
, Xu
X
, Zhang
Y
, Zhang
X
, Chen
H
, et al. Identification and characterization of novel elastin gene mutations in eleven families with supravalvular aortic stenosis
. Front Genet
. 2022
;13
:1059640
. 25.
Tomita-Mitchell
A
, Stamm
KD
, Mahnke
DK
, Kim
MS
, Hidestrand
PM
, Liang
HL
, et al. Impact of MYH6 variants in hypoplastic left heart syndrome
. Physiol Genomics
. 2016
;48
(12
):912
–21
. 26.
Kim
MS
, Fleres
B
, Lovett
J
, Anfinson
M
, Samudrala
SSK
, Kelly
LJ
, et al. Contractility of induced pluripotent stem cell-cardiomyocytes with an MYH6 head domain variant associated with hypoplastic left heart syndrome
. Front Cell Dev Biol
. 2020
;8
:440
. 27.
Pena-Martinez
EG
, Rivera-Madera
A
, Pomales-Matos
DA
, Sanabria-Alberto
L
, Rosario-Cañuelas
BM
, Rodríguez-Ríos
JM
, et al. Disease-associated non-coding variants alter NKX2-5 DNA-binding affinity
. Biochim Biophys Acta Gene Regul Mech
. 2023
;1866
(1
):194906
. 28.
Wu
KH
, Xiao
QR
, Yang
Y
, Xu
JL
, Zhang
F
, Liu
CM
, et al. MicroRNA-34a modulates the Notch signaling pathway in mice with congenital heart disease and its role in heart development
. J Mol Cell Cardiol
. 2018
;114
:300
–8
. 29.
Pang
JKS
, Phua
QH
, Soh
BS
. Applications of miRNAs in cardiac development, disease progression and regeneration
. Stem Cell Res Ther
. 2019
;10
(1
):336
. 30.
Zhang
X
, Gao
Y
, Zhang
X
, Zhang
X
, Xiang
Y
, Fu
Q
, et al. FGD5-AS1 is a hub lncRNA ceRNA in hearts with tetralogy of Fallot which regulates congenital heart disease genes transcriptionally and epigenetically
. Front Cell Dev Biol
. 2021
;9
:630634
. 31.
Hirano
E
, Knutsen
RH
, Sugitani
H
, Ciliberto
CH
, Mecham
RP
. Functional rescue of elastin insufficiency in mice by the human elastin gene: implications for mouse models of human disease
. Circ Res
. 2007
;101
(5
):523
–31
. 32.
He
L
, Zhang
Q
, Jiang
D
, Zhang
Y
, Wei
Y
, Yang
Y
, et al. Zebrafish Foxc1a controls ventricular chamber maturation by directly regulating wwtr1 and nkx2.5 expression
. J Genet Genomics
. 2022
;49
(6
):559
–68
. 33.
Jerome
L
, Papaioannou
V
. DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1
. Nat Genet
. 2001
;27
(3
):286
–91
. 34.
Piotrowski
T
, Ahn
DG
, Schilling
TF
, Nair
S
, Ruvinsky
I
, Geisler
R
, et al. The zebrafish van gogh mutation disrupts tbx1, which is involved in the DiGeorge deletion syndrome in humans
. Development
. 2003
;130
(20
):5043
–52
. 35.
Moore-Morris
T
, van Vliet
PP
, Andelfinger
G
, Puceat
M
. Role of epigenetics in cardiac development and congenital diseases
. Physiol Rev
. 2018
;98
(4
):2453
–75
. 36.
Engwerda
A
, Abbott
KM
, Hitzert
MM
, van Ravenswaaij-Arts
CMA
, Kerstjens-Frederikse
WS
. The role of TBX18 in congenital heart defects in humans not confirmed
. Eur J Hum Genet
. 2023
;31
(2
):138
–41
. 37.
Seok
H
, Deng
R
, Cowan
DB
, Wang
DZ
. Application of CRISPR-Cas9 gene editing for congenital heart disease
. Clin Exp Pediatr
. 2021
;64
(6
):269
–79
. 38.
Tyser
RCV
. Formation of the heart: defining cardiomyocyte progenitors at single-cell resolution
. Curr Cardiol Rep
. 2023
;25
(6
):495
–503
. 39.
De Zoysa
P
, Liu
J
, Toubat
O
, Choi
J
, Moon
A
, Gill
PS
, et al. Delta-like ligand 4-mediated Notch signaling controls proliferation of second heart field progenitor cells by regulating Fgf8 expression
. Development
. 2020
;147
(17
):dev185249
. 40.
De Bono
C
, Thellier
C
, Bertrand
N
, Sturny
R
, Jullian
E
, Cortes
C
, et al. T-box genes and retinoic acid signaling regulate the segregation of arterial and venous pole progenitor cells in the murine second heart field
. Hum Mol Genet
. 2018
;27
(21
):3747
–60
. 41.
Augiere
C
, Megy
S
, El Malti
R
, Boland
A
, El Zein
L
, Verrier
B
, et al. A novel alpha cardiac actin (ACTC1) mutation mapping to a domain in close contact with myosin heavy chain leads to a variety of congenital heart defects, arrhythmia and possibly midline defects
. PLoS One
. 2015
;10
(6
):e0127903
. 42.
Boskovski
MT
, Homsy
J
, Nathan
M
, Sleeper
LA
, Morton
S
, Manheimer
KB
, et al. De novo damaging variants, clinical phenotypes, and post-operative outcomes in congenital heart disease
. Circ Genom Precis Med
. 2020
;13
(4
):e002836
. 43.
Damen
FW
, Gramling
DP
, Ahlf Wheatcraft
D
, Wilpan
RY
, Costa
MW
, Goergen
CJ
. Application of 4-D ultrasound-derived regional strain and proteomics analysis in Nkx2-5-deficient male mice
. Am J Physiol Heart Circ Physiol
. 2023
;325
(2
):H293
–310
. 44.
Blue
GM
, Kirk
EP
, Giannoulatou
E
, Sholler
GF
, Dunwoodie
SL
, Harvey
RP
, et al. Advances in the genetics of congenital heart disease: a clinician's guide
. J Am Coll Cardiol
. 2017
;69
(7
):859
–70
. 45.
Radhakrishna
U
, Albayrak
S
, Zafra
R
, Baraa
A
, Vishweswaraiah
S
, Veerappa
AM
, et al. Placental epigenetics for evaluation of fetal congenital heart defects: ventricular septal defect (VSD)
. PLoS One
. 2019
;14
(3
):e0200229
. 46.
Bahado-Singh
R
, Vishweswaraiah
S
, Mishra
NK
, Guda
C
, Radhakrishna
U
. Placental DNA methylation changes in detection of tetralogy of Fallot
. Ultrasound Obstet Gynecol
. 2020
;55
(6
):768
–75
. 47.
Waugh
KA
, Minter
R
, Baxter
J
, Chi
C
, Galbraith
MD
, Tuttle
KD
, et al. Triplication of the interferon receptor locus contributes to hallmarks of Down syndrome in a mouse model
. Nat Genet
. 2023
;55
(6
):1034
–47
. 48.
Bayne
J
, Garry
J
, Albert
MA
. Brief review: racial and ethnic disparities in cardiovascular care with a focus on congenital heart disease and precision medicine
. Curr Atheroscler Rep
. 2023
;25
(5
):189
–95
. 49.
Acosta
JN
, Falcone
GJ
, Rajpurkar
P
, Topol
EJ
. Multimodal biomedical AI
. Nat Med
. 2022
;28
(9
):1773
–84
. 50.
Hill
MC
, Kadow
ZA
, Long
H
, Morikawa
Y
, Martin
TJ
, Birks
EJ
, et al. Integrated multi-omic characterization of congenital heart disease
. Nature
. 2022
;608
(7921
):181
–91
. © 2024 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2024
You do not currently have access to this content.
